U.S. Consumer Durables Stock News

If you’re debating whether to buy, hold, or move on from Snap stock, you’re definitely not alone. Even the savviest investors can find Snap a bit of a puzzle. After all, in just the past week Snap shares bounced up by 3.9%, but step back to the past month and you’ll see the price actually slipped 3.3%. Glance even further back, such as a year or more, and the ride gets a lot bumpier, with the stock down about 24% over twelve months and more than 79% in five years. That’s a mix of short-term...

Orchid Island Capital reported third-quarter 2025 earnings that exceeded analyst expectations, with net income rising to US$72.08 million and basic earnings per share from continuing operations reaching US$0.53, alongside revenue significantly above consensus forecasts. An important insight is that the company paired this strong performance with robust liquidity, ongoing share repurchases, and confirmation of its monthly dividend, reinforcing management's focus on capital return and...

McKesson (MCK) is drawing attention after posting strong gains over the past month, up 5%. The company’s year-to-date return sits at an impressive 42%, which reflects sustained investor interest throughout 2024. See our latest analysis for McKesson. This latest move builds on what has been a strong run for McKesson, with momentum clearly favoring the bulls. The share price return over the past year has been stellar, and momentum remains strong with a 5.4% gain in the last month. Looking at...

Vicor (VICR) shares have been showing resilience lately, gaining nearly 95% over the past year. The company’s recent performance is drawing attention as investors evaluate its growth potential in the current market environment. See our latest analysis for Vicor. After a stellar 71% share price return in the past month and nearly doubling over the last quarter, Vicor is now attracting plenty of market buzz. This run has added to its 95% total shareholder return over the past year, which...

Cogent Biosciences (COGT) stock has drawn attention lately as investors look closely at how the company’s performance has evolved. Shares have shown meaningful movement over the past month, which makes it a name worth deeper analysis. See our latest analysis for Cogent Biosciences. Cogent Biosciences has seen powerful momentum in its share price lately, with a 14.2% gain over the past month and an impressive year-to-date share price return of nearly 94%. This kind of sharp price action...

Clearwater Analytics and J.P. Morgan Asset Management recently announced an integration that links Enfusion by Clearwater with the Morgan Money trading platform, providing hedge funds an automated workflow for managing and investing idle cash across multiple money market funds, currencies, and providers. This collaboration significantly streamlines cash management processes for hedge funds, aiming to enhance liquidity oversight, diversification, and operational efficiency by automating...

Archrock, Inc.'s Board of Directors declared a quarterly dividend of US$0.21 per share, or US$0.84 annualized, with the third quarter 2025 payout made on November 13, 2025, to shareholders of record as of November 4, 2025. This dividend represents an estimated 20% increase compared to the same quarter last year, indicating the company's increased shareholder return commitments. We'll explore how this significant year-over-year dividend increase shapes Archrock's investment narrative and...

Thinking about what to do with your Henry Schein shares, or maybe considering getting in? You are not alone, since the stock has had quite a ride lately. Although its price recently closed at $63.84, up 1.4% over the past week, there have been some noticeable dips, including a 5.8% slide over the last month and a year-to-date pullback of 6.9%. If you have been holding on for several years, the stock has barely budged in five years, with a total return of just 0.4%, making it a bit of a...

If you are contemplating what to do with International Business Machines stock right now, you are hardly alone. The company’s shares have delivered impressive returns recently, surging 9.3% just in the last week, 14.9% over the past month, and almost 40% since the start of the year. For anyone eyeballing those numbers on their portfolio screen, it raises the obvious question: is IBM still a buy, or has this rally already factored in all the good news? Going further back, IBM’s stock has...

Are you weighing your options on Coca-Cola stock? You are not alone. Whether you are a longtime shareholder, a steady dividend lover, or someone eyeing a reliable blue-chip opportunity, Coca-Cola has probably been on your radar. The stock’s reputation for stability has made it a popular pick, but recent trading action deserves a closer look, especially for anyone trying to decide if this is the moment to buy, hold, or trim their position. In the past week alone, Coca-Cola shares have ticked...

Pentair (PNR) just turned heads with record third-quarter results, revealing both sales and net income growth. In addition to an increased outlook for full-year earnings and sales, the company highlighted momentum from recent transformation initiatives. See our latest analysis for Pentair. Pentair’s series of upbeat developments, including record quarterly results, leadership moves, and continued buybacks, have all added fuel to growing investor optimism. The share price is up 9.3%...

Recently, ADMA Biologics received a more favorable valuation grade following a review of its financial standing, underpinned by 17 consecutive quarters of positive results and robust institutional investor confidence at 98.05% ownership. This significant show of support among large investors underscores a strong belief in ADMA’s fundamentals and sustained operational momentum within the biopharmaceutical sector. With institutional confidence bolstered by clear and consistent financial...

Arcturus Therapeutics Holdings (ARCT) drew intense investor attention after it released interim results from a Phase 2 trial for its cystic fibrosis treatment, ARCT-032. The report showed no substantial lung function improvement, which triggered sharp share declines and analyst downgrades. See our latest analysis for Arcturus Therapeutics Holdings. It has been a turbulent year for Arcturus Therapeutics. Shares have dropped sharply after underwhelming trial news and legal scrutiny, leading to...

CRS Technology Consultants announced in October 2025 that it used N-able's platform to contain and fully recover a regional CPA firm from a major ransomware attack in under 24 hours, with no ransom paid or client data lost during a critical tax period. This incident underlines how N-able's unified endpoint management, behavioral AI, and cloud backup solutions provided a real-world example of business continuity and resilience against evolving cyber threats. We'll explore how this successful...

Atomera (ATOM) is gearing up for its latest earnings report, and expectations are high for a substantial jump in quarterly revenue compared to the same period last year. Investors are watching closely to see how this development will shape the company’s outlook. See our latest analysis for Atomera. Despite anticipation around the upcoming earnings, Atomera’s recent share price momentum has been firmly negative, with a 7-day return of -31.37% and a one-year total shareholder return of -6.25%...

TransUnion (NYSE:TRU) shares advanced after the company delivered third-quarter earnings that surpassed expectations and raised its outlook for both revenue and earnings per share for the full year. The company’s organic revenue growth and expanded share buyback program reinforced confidence in its business momentum. See our latest analysis for TransUnion. TransUnion’s upbeat earnings, new mortgage credit and analytics product rollouts, and increased share repurchases sparked real excitement...

LTC Properties (LTC) just wrapped up its planned sale of seven skilled nursing facilities, bringing in fresh capital earmarked for newer seniors housing assets. This strategic shift reflects the company's continued move toward a more growth-oriented seniors housing portfolio. See our latest analysis for LTC Properties. After a relatively steady few months, LTC Properties’ latest share price stands at $35.34, reflecting a 3.85% share price return since the start of the year. Momentum has been...

Wintrust Financial (WTFC) posted another record quarter, delivering its third consecutive period of record net income. This strong result was supported by solid loan and deposit growth, along with stable credit quality. See our latest analysis for Wintrust Financial. It has been a strong year for Wintrust Financial, with momentum building on the back of steady operational gains and consistent execution. Alongside its record-setting results, shareholders have seen the total return surge 15.98%...

Nextracker (NXT) drew investor attention after releasing quarterly results that topped revenue expectations and raising its full-year revenue outlook. The company also announced a joint venture in Saudi Arabia to support international expansion. See our latest analysis for Nextracker. Nextracker’s momentum has been hard to miss, with a 1-day share price return of 8.7% following its revenue beat and newly announced Saudi joint venture. Over the past year, total shareholder return rose an...

Nomad Foods (NYSE:NOMD) has announced plans to refinance its existing USD and EUR denominated Term Loan B, along with an extension of its EUR 175 million revolving cash facility. These moves can have a real impact on the company’s financial flexibility and overall capital structure. See our latest analysis for Nomad Foods. Nomad Foods’ recent refinancing news comes just as the company prepares to report its latest results, adding fresh context to what has been a challenging year for...

Krispy Kreme (DNUT) just launched an aggressive international expansion by opening its first Madrid shop and announcing new stores in Brazil and Uzbekistan. This franchise-driven strategy coincides with a recent surge in meme-fueled retail trading activity around the stock. See our latest analysis for Krispy Kreme. Krispy Kreme’s bold international push and flashy sponsorship deals have helped fuel a sharp, meme-trader-driven rally in recent weeks, even as the stock remains highly volatile...

If you’re standing on the edge, wondering whether it’s the right moment to jump into Tesla stock or take some profits, you’re not alone. Tesla’s shares have kept investors guessing lately, weaving back and forth with a 1.3% drop this past week but growing 2.4% over the last month. The story gets even more interesting when you widen the lens: up 14.4% since January and an eye-catching 61.1% over the last year. Looking back five years, Tesla’s up an astonishing 235.3%. That kind of performance...

Trying to figure out what to do with Coeur Mining stock? You are not alone. After a remarkable run this year, the share price has skyrocketed by more than 200.8% year-to-date, easily outpacing market averages. Plenty of investors are asking whether it is time to hold, buy, or possibly even take profits. Just this past month, the stock delivered another strong 7.1% gain. However, the last week brought a sharp -11.4% pullback that has some wondering if a reassessment is underway. So what is...

Western Union (NYSE:WU) posted third-quarter earnings that came in ahead of Wall Street predictions for both profit and revenue, creating a wave of renewed attention around the stock. Management’s latest outlook for full-year revenue landed just above expectations, which has fueled optimism among investors. See our latest analysis for Western Union. Western Union’s better-than-expected earnings have powered a rapid rise in its share price, with a standout 10.2% one-day gain and a roughly 8%...